Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial comparing afatinib (BIBW 2992) to gemcitabine-cisplatin in first-line non-small cell lung cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2) [Phase 1]
Phase 1 dose-escalation study evaluating oral BIBF 1120 in combination with intravenous carboplatin and vinorelbine in elderly patients with…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients [Phase 3]
A Phase 3 trial comparing IMN1207 to casein in non-small cell lung cancer was terminated; the update does not report trial results.
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. [Phase 3]
Phase 3 trial evaluating fusidic acid (Verutex), erythromycin (Eritex), and Fisiogel for management of Tarceva-associated rash in non-small …
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 study evaluating carboplatin, paclitaxel, and selenomethionine with radiation therapy for Stage III non-small cell lung cancer that …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer [NA]
This clinical trial update reports results from a study evaluating the use of FDG-PET imaging during radiation therapy for non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer [Phase 1]
Phase I trial of MT110 in multiple solid tumors has completed enrollment, evaluating MT110 in lung cancer (non-small cell and small cell), g…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors [Phase 1]
Phase 1 study evaluating the combination of MGCD0103 and docetaxel in advanced cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study of MGCD265 in combination with erlotinib or docetaxel in patients with advanced malignancies, including non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of eribulin mesylate (E7389) in recurrent or stage IIIB/IV non-small cell lung cancer has completed, and results were posted.
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung [Phase 3]
A Phase 3 trial comparing crizotinib to pemetrexed-platinum chemotherapy in patients with ALK-positive non-small cell lung cancer has comple…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery [Phase 3]
Phase 3 trial evaluating gefitinib after complete surgical removal of stage IB to IIIA non-small cell lung cancer; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC [Phase 2]
Phase II trial of dasatinib in previously treated advanced non-small cell lung cancer was terminated, and the results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVE
Observational study evaluating erlotinib as second-line treatment in patients with squamous cell non-small cell lung cancer and wild-type EG…
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease [Phase 2]
A Phase 2 dose-escalation trial evaluating icotinib in patients with advanced non-small cell lung cancer who had stable disease.
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer [Phase 2]
A Phase 2 study of ramucirumab plus paclitaxel and carboplatin in non-small cell lung cancer completed, with results posted on 2014-12-29.
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy [Phase 3]
Phase 3 study comparing chemotherapy with ramucirumab versus chemotherapy alone in second-line NSCLC after platinum-based first-line therapy…
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial evaluating pemetrexed with best supportive care versus placebo with best supportive care in non-small cell lung cancer has com…
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial update evaluating pemetrexed and platinum combinations with or without IMC-1121B in previously untreated recurrent or advanced…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 trial evaluated the combination of RO4929097, a gamma-secretase inhibitor, with Cediranib maleate in adults with advanced solid…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy [Phase 2]
Phase 2 study evaluating Tarceva (erlotinib) in patients with advanced non-small cell lung cancer who have not received chemotherapy, with r…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial [Phase 2]
Phase 2 trial evaluating gefitinib plus vinorelbine in advanced EGFR-mutated non-small cell lung cancer (GENOA trial) with status currently …
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Personalized Therapy in Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update for personalized therapy in non-small cell lung cancer has completed. The summary does not include detailed trial resul…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer. [Phase 2]
A Phase 2 trial evaluating a new chemotherapy agent for non-small cell lung cancer reports safety and efficacy results.
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Utility of Routine Cervical Mediastinoscopy in Clinical Stage I Non-Small Cell Lung Cancer (NSCLC)
This completed trial evaluated whether routine cervical mediastinoscopy adds value for staging patients with clinical stage I non-small cell…